Hexagon Bio-Pharma Private Limited

Hexagon Bio-Pharma Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN U24232KA2006PTC040046 Incorporated 26 July 2006 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹6.47 Cr
▲ 30% YoY
Net loss · FY 2025
₹1.08 Cr
Net margin -16.7%
EBITDA · FY 2025
₹44.08 Lakh
EBITDA margin 6.8%
Authorised capital
₹2.2 Cr
Registered with MCA
Paid-up capital
₹2.18 Cr
Issued & subscribed
Open charges
₹7.85 Cr
Satisfied ₹4.79 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
27
Provident fund records

About Hexagon Bio-Pharma Private Limited

Data last updated:

Hexagon Bio-Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 26 July 2006 and has been in existence for over 20 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24232KA2006PTC040046. Its GSTIN is 29AABCH7521D1ZS (Karnataka).

The company has an authorised share capital of ₹2.2 Cr and a paid-up capital of ₹2.18 Cr. It is led by directors Shridhar Punachithaya Kolya (Whole-Time Director) and Shashirekha Kolya.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.11 – D KIADB Industrial Area Doddaballapur, Bangalore, Karnataka, India – 561203.

As per the financials filed for FY 2025, the company reported a revenue of ₹6.47 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net loss of ₹1.08 Cr (net margin -16.7%) and EBITDA of ₹44.08 Lakh (EBITDA margin 6.8%). Revenue has declined at a compounded annual rate (CAGR) of 18% over three years and 11% over five years.

The company has about 27 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Hexagon Bio-Pharma. As per MCA filings, the company has open charges of ₹7.85 Cr and satisfied charges of ₹4.79 Cr on record. Court records list 6 cases involving the company, including 2 filed by the company and 4 filed against it; 1 case is pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hexagonbiopharma.in.

Company details

CIN U24232KA2006PTC040046
Registration Number 040046
Incorporation Date 26 July 2006
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant

Contact details

Hexagon Bio-Pharma Private Limited's registered office is in Bangalore, Karnataka. Its website is hexagonbiopharma.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No.11 – D KIADB Industrial Area Doddaballapur, Bangalore, Karnataka, India – 561203
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Hexagon Bio-Pharma Private Limited, buy the company report.

Comprehensive company report
Hexagon Bio-Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Hexagon Bio-Pharma operates one associated brand: Hexagon Bio-Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturing of pharmaceutical APIs, intermediates, and speciality chemicals in India.hexagonbiopharma.in

Business activity

The main business activity of Hexagon Bio-Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of Hexagon Bio-Pharma Private Limited, buy the company report.

Financials of Hexagon Bio-Pharma Private Limited

FY 2024 filings available

Hexagon Bio-Pharma Private Limited reported revenue of ₹6.47 Cr (up 30% YoY) for FY 2025.

Revenue · FY 2025
₹6.47 Cr ▲ 30%
Net loss · FY 2025
₹1.08 Cr margin -16.7%
EBITDA · FY 2025
₹44.08 Lakh margin 6.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 30%
3 years · compounded
▲ 18%
5 years · compounded
▼ 11%
EBITDA CAGR growth
1 year
▼ 62%
3 years · compounded
▲ 35%
5 years · compounded
▼ 11%

Revenue rose 30% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 11%. EBITDA fell 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹44.08 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.08 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin6.8%
Net Profit Margin-16.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Hexagon Bio-Pharma Private Limited, buy the company report.

Board of directors of Hexagon Bio-Pharma Private Limited

Hexagon Bio-Pharma has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Shashirekha KolyaDirector02 Nov 20232 Years 11 MonthsCurrent
Shridhar Punachithaya KolyaWhole-Time Director02 Jul 20188 Years 3 MonthsCurrent

Auditor

Hexagon Bio-Pharma Private Limited is audited by Shashi Kumar C G & Co for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Shashi Kumar C G & CoFY 2023018385S

Shareholding

The shareholding of Hexagon Bio-Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Hexagon Bio-Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹7.85 Cr
Satisfied charges
₹4.79 Cr
Breakdown by lending institutions
Others₹4.32 Cr
Tata Capital Housing Finance Limited₹3.46 Cr
Vijaya Bank₹0.07 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
19 Nov 2024101008925Others₹4.32 CrOpen
24 Jan 2024100859016Tata Capital Housing Finance Limited₹3.46 CrOpen
29 Aug 200810125693Vijaya Bank₹6.75 LakhOpen
19 Jan 2021100456219Others₹3 CrSatisfied
24 Mar 200710048276Others₹1.79 CrSatisfied

To see the full charge records of Hexagon Bio-Pharma Private Limited, buy the company report.

Total charge records: 5 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Hexagon Bio-Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Hexagon Bio-Pharma Private Limited has a workforce of 27 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.

Employee count
27
Active EPFO establishments
1
Employee growth
-3.57%

GST

Hexagon Bio-Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
29AABCH7521D1ZSKarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Hexagon Bio-Pharma Private Limited, buy the company report.

Recent activity

Hexagon Bio-Pharma Private Limited has 11 board changes on record since 2018: 2 appointments and 9 cessations. The latest: Shashirekha Kolya ceased to be Additional Director on 29 Sep 2024.

Charges
A charge with Others amounted to Rs. 4.32 Cr with Charge ID 101008925 was registered on 19 Nov 2024.
AGM
Hexagon Bio-Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Shashirekha Kolya ceased to be Additional Director.
Filing
Hexagon Bio-Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
Charges
A charge registered on 19 Jan 2021 via Charge ID 100456219 with Others was fully satisfied on 07 Feb 2024.
Charges
A charge with Tata Capital Housing Finance Limited amounted to Rs. 3.46 Cr with Charge ID 100859016 was registered on 24 Jan 2024.
Appointed
Shashirekha Kolya was appointed as Director.
Ceased
Drishya Balakrishna Shetty ceased to be Director.
Charges
A charge with Others amounted to Rs. 3.00 Cr with Charge ID 100456219 was registered on 19 Jan 2021.
Charges
A charge registered on 24 Mar 2007 via Charge ID 10048276 with Others was fully satisfied on 13 Jan 2021.
Ceased
Gangadharaiah Harsha ceased to be Director.
Ceased
Manjunath Govindaiah ceased to be Director.

10 earlier events are in the company report.

Frequently asked questions

Hexagon Bio-Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 26 July 2006 (20+ years old) and is registered under CIN U24232KA2006PTC040046.

Hexagon Bio-Pharma has 2 current directors:

The latest financial statements of Hexagon Bio-Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Hexagon Bio-Pharma is 29AABCH7521D1ZS, registered in Karnataka.

The CIN (Corporate Identification Number) of Hexagon Bio-Pharma is U24232KA2006PTC040046. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Hexagon Bio-Pharma has 6 court cases on record: 2 filed by the company and 4 filed against it. 1 is pending. Most are in the district courts.

Hexagon Bio-Pharma was incorporated on 26 July 2006, making it 20+ years old. It is registered with the Registrar of Companies, Bangalore.

Shashirekha Kolya ceased to be Additional Director on 29 Sep 2024. Shashirekha Kolya was appointed as Director on 02 Nov 2023. Drishya Balakrishna Shetty ceased to be Director on 26 Oct 2023. Hexagon Bio-Pharma has 11 board changes on record in total.

Hexagon Bio-Pharma can be reached through the website hexagonbiopharma.in. Its registered office is in Bangalore, Karnataka, India.

The registered office of Hexagon Bio-Pharma is at Plot No.11 – D KIADB Industrial Area Doddaballapur, Bangalore, Karnataka, India – 561203.